5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE...

por Eleftheriou, P., Sharif, J., Kesse-Adu, R., Filian-Gloor, M., Agrawal, A., Barcelos, G., Telfer, P.
Publicado 2023